Ank N - Search Results

1

Type III interferon (IFN) induces a type I IFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mitogen-activated protein kinases.

Zhou Z, Hamming OJ, Ank N, Paludan SR, Nielsen AL, Hartmann R. Zhou Z, et al. Among authors: ank n. J Virol. 2007 Jul;81(14):7749-58. doi: 10.1128/JVI.02438-06. Epub 2007 May 16. J Virol. 2007. PMID: 17507495 Free PMC article.

2

Age-dependent role for CCR5 in antiviral host defense against herpes simplex virus type 2.

Ank N, Petersen K, Malmgaard L, Mogensen SC, Paludan SR. Ank N, et al. J Virol. 2005 Aug;79(15):9831-41. doi: 10.1128/JVI.79.15.9831-9841.2005. J Virol. 2005. PMID: 16014944 Free PMC article.

3

Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.

Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR. Ank N, et al. J Virol. 2006 May;80(9):4501-9. doi: 10.1128/JVI.80.9.4501-4509.2006. J Virol. 2006. PMID: 16611910 Free PMC article.

4

IFN-lambda: novel antiviral cytokines.

Ank N, West H, Paludan SR. Ank N, et al. J Interferon Cytokine Res. 2006 Jun;26(6):373-9. doi: 10.1089/jir.2006.26.373. J Interferon Cytokine Res. 2006. PMID: 16734557 Review.

5

Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems.

Rasmussen SB, Sørensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, Paludan SR. Rasmussen SB, et al. Among authors: ank n. J Virol. 2007 Dec;81(24):13315-24. doi: 10.1128/JVI.01167-07. Epub 2007 Oct 3. J Virol. 2007. PMID: 17913820 Free PMC article.

6

An important role for type III interferon (IFN-lambda/IL-28) in TLR-induced antiviral activity.

Ank N, Iversen MB, Bartholdy C, Staeheli P, Hartmann R, Jensen UB, Dagnaes-Hansen F, Thomsen AR, Chen Z, Haugen H, Klucher K, Paludan SR. Ank N, et al. J Immunol. 2008 Feb 15;180(4):2474-85. doi: 10.4049/jimmunol.180.4.2474. J Immunol. 2008. PMID: 18250457

7

Type III IFNs: new layers of complexity in innate antiviral immunity.

Ank N, Paludan SR. Ank N, et al. Biofactors. 2009 Jan-Feb;35(1):82-7. doi: 10.1002/biof.19. Biofactors. 2009. PMID: 19319850 Review.

8

Expression of type III interferon (IFN) in the vaginal mucosa is mediated primarily by dendritic cells and displays stronger dependence on NF-kappaB than type I IFNs.

Iversen MB, Ank N, Melchjorsen J, Paludan SR. Iversen MB, et al. Among authors: ank n. J Virol. 2010 May;84(9):4579-86. doi: 10.1128/JVI.02591-09. Epub 2010 Feb 24. J Virol. 2010. PMID: 20181703 Free PMC article.

9

Characterisation of a multidrug-resistant Bacteroides fragilis isolate recovered from blood of a patient in Denmark using whole-genome sequencing.

Ank N, Sydenham TV, Iversen LH, Justesen US, Wang M. Ank N, et al. Int J Antimicrob Agents. 2015 Jul;46(1):117-20. doi: 10.1016/j.ijantimicag.2015.02.024. Epub 2015 Apr 17. Int J Antimicrob Agents. 2015. PMID: 25940770

10

Research Electronic Data Capture (REDCap®) used as an audit tool with a built-in database.

Kragelund SH, Kjærsgaard M, Jensen-Fangel S, Leth RA, Ank N. Kragelund SH, et al. Among authors: ank n. J Biomed Inform. 2018 May;81:112-118. doi: 10.1016/j.jbi.2018.04.005. Epub 2018 Apr 9. J Biomed Inform. 2018. PMID: 29649526 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters